Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HBMN.SW Stock Summary
Top 10 Correlated ETFs
HBMN.SW
In the News
HBMN.SW Financial details
Company Rating
Sell
Market Cap
1.31B
Income
-149.14M
Revenue
-147.04M
Book val./share
224.36
Cash/share
1.14
Dividend
7.5
Dividend %
4.19%
Employees
-
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
-6.82
Forward P/E
-
PEG
-0.75
P/S
-7.01
P/B
0.75
P/C
162.46
P/FCF
-884.49
Quick Ratio
0.04
Current Ratio
0.04
Debt / Equity
0.06
LT Debt / Equity
0.06
-
-
EPS (TTM)
-21.48
EPS next Y
-
EPS next Q
-
EPS this Y
87.43%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
NAN%
Revenue Q/Q
47.75%
EPS Q/Q
47.31%
-
-
-
-
SMA20
-0.11%
SMA50
5.3%
SMA100
13.95%
Inst Own
-
Inst Trans
-
ROA
-10%
ROE
-11%
ROC
-0.1%
Gross Margin
100%
Oper. Margin
101%
Profit Margin
101%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
135.2-249.23
52W High
-25.62%
52W Low
+37.19%
RSI
45.16
Rel Volume
0.43
Avg Volume
6.82K
Volume
2.96K
Perf Week
-2.73%
Perf Month
1.76%
Perf Quarter
22.65%
Perf Half Y
21.05%
-
-
-
-
Beta
0.805
-
-
Volatility
1.91%, 3.11%
Prev Close
-0.43%
Price
185.2
Change
-0.64%
HBMN.SW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 30.63 | 26.76 | 110.15 | -11 | -20.83 | |
Net income per share | 30.05 | 26.26 | 108.71 | -11.22 | -21.03 | |
Operating cash flow per share | -0.41 | -0.6 | -0.46 | -1.47 | -0.19 | |
Free cash flow per share | -0.41 | -0.6 | -0.46 | -1.47 | -0.19 | |
Cash per share | 0.68 | 0.88 | 0.87 | 0.77 | 0.82 | |
Book value per share | 189.49 | 208.25 | 309.25 | 285.54 | 254.81 | |
Tangible book value per share | 189.49 | 208.25 | 309.25 | 285.54 | 254.81 | |
Share holders equity per share | 189.49 | 208.25 | 309.25 | 285.54 | 254.81 | |
Interest debt per share | 14.64 | 14.66 | 14.7 | 21.8 | 21.82 | |
Market cap | 1.18B | 1.32B | 2.31B | 1.92B | 1.49B | |
Enterprise value | 1.27B | 1.42B | 2.41B | 2.06B | 1.63B | |
P/E ratio | 5.64 | 7.24 | 3.06 | -24.61 | -10.18 | |
Price to sales ratio | 5.53 | 7.1 | 3.02 | -25.1 | -10.27 | |
POCF ratio | -413.22 | -317.9 | -717.05 | -188.3 | -1.16K | |
PFCF ratio | -413.22 | -317.9 | -717.05 | -188.3 | -1.16K | |
P/B Ratio | 0.89 | 0.91 | 1.08 | 0.97 | 0.84 | |
PTB ratio | 0.89 | 0.91 | 1.08 | 0.97 | 0.84 | |
EV to sales | 5.98 | 7.6 | 3.14 | -26.98 | -11.26 | |
Enterprise value over EBITDA | -523.1 | 7.64 | 3.17 | -27.4 | -11.17 | |
EV to operating cash flow | -446.43 | -340.38 | -746.11 | -202.38 | -1.27K | |
EV to free cash flow | -446.43 | -340.38 | -746.11 | -202.38 | -1.27K | |
Earnings yield | 0.18 | 0.14 | 0.33 | -0.04 | -0.1 | |
Free cash flow yield | 0 | 0 | 0 | -0.01 | 0 | |
Debt to equity | 0.08 | 0.07 | 0.05 | 0.07 | 0.08 | |
Debt to assets | 0.07 | 0.06 | 0.04 | 0.07 | 0.08 | |
Net debt to EBITDA | -38.91 | 0.5 | 0.12 | -1.91 | -0.98 | |
Current ratio | 1.05 | 1.6 | 0.1 | 2.64 | 0.11 | |
Interest coverage | 86.86 | 76.03 | 306.93 | -27.72 | -54.24 | |
Income quality | -0.01 | -0.02 | 0 | 0.13 | 0.01 | |
Dividend Yield | 0.03 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.18 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0 | 0.01 | -0.02 | -0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 357.94 | 350.78 | 869.72 | 268.44 | 347.24 | |
ROIC | 0.15 | 0.12 | 0.34 | -0.04 | -0.07 | |
Return on tangible assets | 0.15 | 0.12 | 0.33 | -0.04 | -0.08 | |
Graham Net | -14.25 | -13.98 | -15 | -20.92 | -20.93 | |
Working capital | 238K | 2.3M | -54.54M | 3.36M | -46.4M | |
Tangible asset value | 1.32B | 1.45B | 2.15B | 1.99B | 1.77B | |
Net current asset value | -99.16M | -97.27M | -104.35M | -145.56M | -145.61M | |
Invested capital | 0.08 | 0.07 | 0.05 | 0.07 | 0.08 | |
Average receivables | 31.5K | 26.5K | 22K | 18.5K | 18K | |
Average payables | 1.53M | 1.81M | 788K | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0.04 | 0.05 | 0.01 | -0.1 | -0.04 | |
Days payables outstanding | -305.02 | -236.34 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 8.19K | 6.9K | 45.08K | -3.83K | -9.06K | |
Payables turnover | -1.2 | -1.54 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 2654289.79B | 0 | 0 | |
ROE | 0.16 | 0.13 | 0.35 | -0.04 | -0.08 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | -17.27 | 1.26 | -1.49 | -8.44 | -12.51 | |
Net income per share | -17.32 | 1.21 | -1.57 | -8.54 | -12.58 | |
Operating cash flow per share | -0.04 | -0.03 | -0.08 | -0.06 | 0 | |
Free cash flow per share | -0.04 | -0.03 | -0.08 | -0.06 | 0 | |
Cash per share | 0.85 | 0.82 | 0.68 | 0.65 | 1.14 | |
Book value per share | 253.6 | 254.81 | 253.2 | 237.2 | 224.36 | |
Tangible book value per share | 264.08 | 255.12 | 253.2 | 237.2 | 241.26 | |
Share holders equity per share | 253.6 | 254.81 | 253.2 | 237.2 | 224.36 | |
Interest debt per share | 21.53 | 21.54 | 21.55 | 14.33 | 14.38 | |
Market cap | 1.4B | 1.49B | 1.41B | 1.22B | 1.27B | |
Enterprise value | 1.54B | 1.63B | 1.55B | 1.32B | 1.36B | |
P/E ratio | -2.9 | 44.28 | -32.21 | -5.15 | -3.63 | |
Price to sales ratio | -11.64 | 169.88 | -135.86 | -20.82 | -14.59 | |
POCF ratio | -5.68K | -6.92K | -2.46K | -3.08K | 0 | |
PFCF ratio | -5.68K | -6.92K | -2.46K | -3.08K | 0 | |
P/B Ratio | 0.79 | 0.84 | 0.8 | 0.74 | 0.81 | |
PTB ratio | 0.79 | 0.84 | 0.8 | 0.74 | 0.81 | |
EV to sales | -12.83 | 186.25 | -149.84 | -22.44 | -15.65 | |
Enterprise value over EBITDA | -12.79 | 194.2 | -2.36K | -4.16K | -15.56 | |
EV to operating cash flow | -6.27K | -7.59K | -2.71K | -3.32K | 0 | |
EV to free cash flow | -6.27K | -7.59K | -2.71K | -3.32K | 0 | |
Earnings yield | -0.09 | 0.01 | -0.01 | -0.05 | -0.07 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.08 | 0.08 | 0.08 | 0.06 | 0.06 | |
Debt to assets | 0.08 | 0.08 | 0.08 | 0.05 | 0.06 | |
Net debt to EBITDA | -1.19 | 17.07 | -220.29 | -298.88 | -1.05 | |
Current ratio | 0.05 | 0.11 | 0.09 | 0.04 | 0 | |
Interest coverage | -185.1 | 12.73 | -15.51 | -154.67 | -266.77 | |
Income quality | 0 | -0.03 | 0.05 | 0.01 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.07 | -0.01 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 314.37 | 83.23 | 94.51 | 213.52 | 252.05 | |
ROIC | 0 | 0 | -0.01 | -0.03 | -0.05 | |
Return on tangible assets | -0.06 | 0 | -0.01 | -0.03 | -0.05 | |
Graham Net | -20.58 | -20.62 | -21.18 | -28.87 | -13.19 | |
Working capital | -116.93M | -46.4M | -48.08M | -101.43M | 7.94M | |
Tangible asset value | 1.84B | 1.77B | 1.76B | 1.65B | 1.67B | |
Net current asset value | -143.14M | -143.44M | -147.33M | -200.72M | -91.4M | |
Invested capital | 0.08 | 0.08 | 0.08 | 0.06 | 0.06 | |
Average receivables | 35.5K | 22.5K | 29.5K | 53.5K | 61.5K | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | -0.02 | 0.16 | -0.37 | -0.1 | -0.06 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | -4.14K | 547.75 | -240.51 | -917.38 | -1.47K | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.07 | 0 | -0.01 | -0.04 | -0.06 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
HBMN.SW Frequently Asked Questions
What is HBM Healthcare Investments AG stock symbol ?
HBM Healthcare Investments AG is a CH stock and trading under the symbol HBMN.SW
What is HBM Healthcare Investments AG stock quote today ?
HBM Healthcare Investments AG stock price is $185.2 today.
Is HBM Healthcare Investments AG stock public?
Yes, HBM Healthcare Investments AG is a publicly traded company.